Pendal Group LTD Gilead Sciences, Inc. Transaction History

Pendal Group LTD

$12.2 Billion
Q4 2022

A detailed history of Pendal Group LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pendal Group LTD holds 40,770 shares of GILD stock, worth $3.59 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

40,770

Previous 28,479 43.16%

Holding current value

$3.59 Million

Previous $1.76 Million 99.2%

% of portfolio

0.03%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	BUY	$62.32 - $89.47 $765,975 - $1.1 Million	12,291 Added 43.16%	40,770 $0
Q3 2022 Oct 18, 2022	SELL	$59.54 - $68.01 $3.3 Million - $3.77 Million	-55,486 Reduced 66.08%	28,479 $1.76 Million
Q2 2022 Jul 25, 2022	BUY	$57.72 - $65.01 $2.94 Million - $3.32 Million	51,019 Added 154.86%	83,965 $5.19 Million
Q1 2022 Apr 25, 2022	BUY	$57.92 - $72.58 $1.62 Million - $2.03 Million	27,965 Added 561.43%	32,946 $1.96 Million
Q3 2021 Nov 05, 2021	SELL	$67.69 - $73.03 $19,833 - $21,397	-293 Reduced 5.56%	4,981 $348,000
Q2 2021 Jul 28, 2021	SELL	$63.47 - $69.35 $1.43 Million - $1.56 Million	-22,535 Reduced 81.03%	5,274 $363,000
Q1 2021 May 24, 2021	BUY	$60.0 - $68.46 $1.67 Million - $1.9 Million	27,809 New	27,809 $1.8 Million
Q1 2021 May 03, 2021	SELL	$60.0 - $68.46 $2.38 Million - $2.71 Million	-39,650 Closed	0 $0
Q4 2020 Jan 21, 2021	SELL	$56.65 - $64.55 $833,434 - $949,659	-14,712 Reduced 27.06%	39,650 $2.31 Million
Q3 2020 Nov 02, 2020	SELL	$62.1 - $78.08 $925,476 - $1.16 Million	-14,903 Reduced 21.52%	54,362 $3.44 Million
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $174,411 - $202,524	-2,411 Reduced 3.36%	69,265 $5.33 Million
Q1 2020 May 04, 2020	SELL	$62.63 - $80.22 $4.89 Million - $6.26 Million	-78,032 Reduced 52.12%	71,676 $5.36 Million
Q4 2019 Feb 06, 2020	BUY	$61.62 - $67.78 $2.74 Million - $3.01 Million	44,469 Added 42.26%	149,708 $9.73 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $2.7 Million - $2.98 Million	-43,138 Reduced 29.07%	105,239 $6.67 Million
Q2 2019 Aug 01, 2019	SELL	$61.87 - $69.38 $873,975 - $980,061	-14,126 Reduced 8.69%	148,377 $0
Q1 2019 May 01, 2019	BUY	$62.53 - $70.05 $2.2 Million - $2.47 Million	35,206 Added 27.66%	162,503 $0
Q4 2018 Jan 30, 2019	SELL	$60.54 - $79.0 $1.44 Million - $1.87 Million	-23,713 Reduced 15.7%	127,297 $7.96 Million
Q3 2018 Nov 05, 2018	SELL	$71.28 - $78.92 $1.76 Million - $1.95 Million	-24,686 Reduced 14.05%	151,010 $0
Q1 2018 May 08, 2018	SELL	$72.84 - $88.8 $9.99 Million - $12.2 Million	-137,202 Reduced 43.85%	175,696 $0
Q4 2017 Feb 06, 2018	SELL	$71.15 - $83.52 $7.44 Million - $8.74 Million	-104,608 Reduced 25.06%	312,898 $0
Q3 2017 Nov 01, 2017	BUY	$72.11 - $85.47 $7.62 Million - $9.03 Million	105,689 Added 33.89%	417,506 $0
Q2 2017 Aug 11, 2017	BUY	N/A	311,817	311,817 $0

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Account